Last update 14 Dec 2024

Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)

Overview

Basic Info

Drug Type
Non-recombinant coagulation factor
Synonyms
人凝血因子VIII (广东双林生物)
Target
F10
Mechanism
F10 stimulants(Coagulation factor X stimulants), Coagulation factor VIII replacements
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication
Hemophilia A
Inactive Indication-
Originator Organization
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Active Organization
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (22 Jun 2020),
Hemophilia A
RegulationPriority Review (CN)
Login to view timeline

Related

1
Clinical Trials associated with Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)
CTR20160129 / CompletedPhase 3
单臂、开放性、多中心临床试验评价人凝血因子Ⅷ治疗甲型血友病的安全性和有效性
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the safety and efficacy of human coagulation factor VIII in the treatment of hemophilia A
100 Clinical Results associated with Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)
Login to view more data
100 Translational Medicine associated with Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)
Login to view more data
100 Patents (Medical) associated with Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)
Login to view more data
2
Literatures (Medical) associated with Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)
01 Jul 1971Vox sanguinisQ4 · MEDICINE
Q4 · MEDICINE
01 Jan 1969Acta haematologicaQ4 · MEDICINE
Le rôle des inhibiteurs faibles du facteur VIII
Q4 · MEDICINE
100 Deals associated with Factor VIII (Guangdong Shuanglin Biological Pharmaceutical)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia A
CN
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
22 Jun 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free